NCT00264706View on ClinicalTrials.gov

PolyArginine Treated vEiN grafTs (PATENT)

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Saphenous Vein Graft Disease

Interventions

DRUG

Nona-L-arginine

Trial Locations (1)

M5G 2C4

Toronto General Hospital, Toronto

Sponsors

Lead Sponsor

Lumen Therapeutics

All Listed Sponsors

lead

Lumen Therapeutics

INDUSTRY